A doctor may review dose timing, dose amount, titration speed, meal size, food choices, hydration, constipation, reflux, gallbladder symptoms, and other medications
Wegovy is now uniquely positioned as the first and only GLP-1 treatment approved for MASH, complementing the already proven weight loss, cardiovascular benefits and extensive body of evidence linked to semaglutide, said Martin Holst Lange, executive vice president, chief scientific officer and head of Research and Development, at Novo Nordisk
Thankfully, it has been observed that semaglutide is also useful in ensuring glycemic control
What happens if I draw the wrong number of units
Rare but Serious Side Effects: Pancreatitis Severe abdominal pain radiating to the back